IL100603A - Bipyridyls are transformed into a process for their preparation and pharmaceutical preparations containing them - Google Patents

Bipyridyls are transformed into a process for their preparation and pharmaceutical preparations containing them

Info

Publication number
IL100603A
IL100603A IL10060392A IL10060392A IL100603A IL 100603 A IL100603 A IL 100603A IL 10060392 A IL10060392 A IL 10060392A IL 10060392 A IL10060392 A IL 10060392A IL 100603 A IL100603 A IL 100603A
Authority
IL
Israel
Prior art keywords
formula
radicals
lower alkyl
compound
salt
Prior art date
Application number
IL10060392A
Other languages
English (en)
Hebrew (he)
Other versions
IL100603A0 (en
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of IL100603A0 publication Critical patent/IL100603A0/xx
Publication of IL100603A publication Critical patent/IL100603A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/83—Thioacids; Thioesters; Thioamides; Thioimides

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
IL10060392A 1991-01-14 1992-01-07 Bipyridyls are transformed into a process for their preparation and pharmaceutical preparations containing them IL100603A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH8591 1991-01-14

Publications (2)

Publication Number Publication Date
IL100603A0 IL100603A0 (en) 1992-09-06
IL100603A true IL100603A (en) 1996-05-14

Family

ID=4178927

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10060392A IL100603A (en) 1991-01-14 1992-01-07 Bipyridyls are transformed into a process for their preparation and pharmaceutical preparations containing them

Country Status (13)

Country Link
US (1) US5354761A (fr)
EP (1) EP0495749A1 (fr)
JP (1) JPH04312576A (fr)
KR (1) KR920014796A (fr)
AU (1) AU648377B2 (fr)
CA (1) CA2059051A1 (fr)
HU (1) HU214339B (fr)
IE (1) IE920094A1 (fr)
IL (1) IL100603A (fr)
MA (1) MA22385A1 (fr)
MX (1) MX9200120A (fr)
ZA (1) ZA92224B (fr)
ZW (1) ZW692A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69615669T2 (de) * 1995-03-15 2002-07-11 Novartis Ag, Basel Piperidenyl-2-alkyl substituierte lineare polyamine zur senkung intrazellulärer, endogener polyaminkonzentrationen wie z.b. putrescin, spermidin und spermin und ihr einfluss auf die zellvermehrung
AU8704101A (en) * 2000-09-01 2002-03-13 Biogen Inc Novel cd40:cd154 binding interruptor compounds and use thereof to treat immunological complications

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4086244A (en) * 1976-12-10 1978-04-25 E. R. Squibb & Sons, Inc. Amidines
US4495934A (en) * 1978-07-25 1985-01-29 Shaw Jr Seth T IUD Arrangement
US4284074A (en) * 1978-07-26 1981-08-18 Shaw Jr Seth T IUD Arrangement
AU538963B2 (en) * 1979-07-09 1984-09-06 Seth Thomas Shaw Jr. Drug for use with an iud
DOP1981004033A (es) * 1980-12-23 1990-12-29 Ciba Geigy Ag Procedimiento para proteger plantas de cultivo de la accion fitotoxica de herbicidas.
US4598073A (en) * 1982-12-06 1986-07-01 Research Corporation Certain polycyclo-palladium-bipyridine complexes having anti-tumor activity
MX16687A (es) * 1988-07-07 1994-01-31 Ciba Geigy Ag Compuestos de biarilo y procedimiento para su preparacion.

Also Published As

Publication number Publication date
HU9200105D0 (en) 1992-04-28
MX9200120A (es) 1992-12-01
HU214339B (hu) 1998-03-02
MA22385A1 (fr) 1992-10-01
AU1017692A (en) 1992-07-16
JPH04312576A (ja) 1992-11-04
EP0495749A1 (fr) 1992-07-22
KR920014796A (ko) 1992-08-25
ZA92224B (en) 1992-08-26
HUT63832A (en) 1993-10-28
CA2059051A1 (fr) 1992-07-15
US5354761A (en) 1994-10-11
IL100603A0 (en) 1992-09-06
IE920094A1 (en) 1992-07-15
ZW692A1 (en) 1992-08-08
AU648377B2 (en) 1994-04-21

Similar Documents

Publication Publication Date Title
US5064832A (en) Biaryl compounds
US4971986A (en) Arylhydrazones useful as SAMDC inhibitors
BG62023B2 (bg) Тетрахидробензтиазоли,метод за получаването и приложението им като междинни продукти или като лекарствени средства
US3632645A (en) Substituted phenylacetyl derivatives of guanidine o-alkylisoureas s-alkylisothioureas and p-nitrobenzylisothiourea
US9309203B2 (en) Malignant and non-malignant disease treatment with Ras antagonists
US3862152A (en) 3-carbamoylamino-4-phenyl quinoline compounds
CA2041832C (fr) Hydrazones
US5354761A (en) Bipyridyls
US5376685A (en) Arylhydrazones using as SAMDC inhibitors
EP0290558B1 (fr) Agents antifolate
NZ241272A (en) 6,6'-(di)amidine, (di)carboxamido and (di)thiocarboxamido-2,2'-bipyridine derivatives; preparatory processes and pharmaceutical compositions
US4713390A (en) Sulfurated hydantoin derivatives and pharmaceutical compositions containing same
US4576948A (en) Composition and method for inhibiting terminal deoxyribonucleotidyl transferase activity
US4745118A (en) Substituted quinazoline-3-oxides providing pharmacological activity
HU226954B1 (en) Process for producing hydrazonic acids and pharmaceutical composition containing them
EP0072761B1 (fr) Dérivés fluorés d'alcandiamines avec activité inhibitante sur le décarboxylase
US3755326A (en) Uracil thioureas
TW299322B (fr)

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
RH Patent void